Integrin inhibitors for the treatment of eye diseases

Methods for the treatment of a disease of the eye of a patient comprising injecting into the vitreous body of the eye a composition comprising a therapeutically effective amount of an alphavbeta3 and/or alphavbeta5 inhibitor sufficient to inhibit angiogenesis and inhibit neovascularization in the tr...

Full description

Saved in:
Bibliographic Details
Main Authors BENDER HANS-MARKUS, FRIEDLANDER MARTIN, WIESNER MATTHIAS, LANG ULRICH, HAUNSCHILD JUTTA
Format Patent
LanguageEnglish
Published 12.01.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Methods for the treatment of a disease of the eye of a patient comprising injecting into the vitreous body of the eye a composition comprising a therapeutically effective amount of an alphavbeta3 and/or alphavbeta5 inhibitor sufficient to inhibit angiogenesis and inhibit neovascularization in the treated eye. The alphavbeta3 and/or alphavbeta5 inhibitor being a compound of formula II: as defined herein or a physiologically acceptable salt thereof.
Bibliography:Application Number: US20060510596